Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/10/2026 | 18,094 | 0.1% | 23,442 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 13,755 | 0.1% | 24,463 | 9/30/2025 |
| 2025 Q2 | 8/8/2025 | 13,371 | 0.1% | 25,469 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 15,260 | 0.1% | 24,060 | 3/31/2025 |
| 2024 Q4 | 2/11/2025 | 15,945 | 0.1% | 22,384 | 12/31/2024 |
| 2024 Q3 | 11/7/2024 | 24,285 | 0.2% | 23,101 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 24,487 | 0.2% | 23,298 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 22,322 | 0.2% | 23,192 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 20,605 | 0.1% | 23,460 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 17,662 | 0.1% | 21,462 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 13,521 | 0.1% | 18,817 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 14,975 | 0.1% | 18,225 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 13,060 | 0.1% | 18,101 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 10,801 | 0.1% | 15,679 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 9,298 | 0.1% | 15,729 | 6/30/2022 |
| 2022 Q1 | 5/12/2022 | 9,973 | 0.1% | 14,279 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 8,380 | 0.1% | 13,270 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 7,971 | 0.1% | 13,172 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 7,326 | 0.1% | 13,117 | 6/30/2021 |
| 2021 Q1 | 5/12/2021 | 6,230 | 0.1% | 13,167 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 6,330 | 0.1% | 13,102 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 5,422 | 0.1% | 9,686 | 9/30/2020 |
| 2020 Q2 | 8/11/2020 | 3,597 | 0.1% | 5,768 | 6/30/2020 |
| 2020 Q1 | 5/14/2020 | 2,492 | 0.1% | 5,103 | 3/31/2020 |
| 2019 Q4 | 2/11/2020 | 1,931 | 0.0% | 5,144 | 12/31/2019 |
| 2014 Q1 | 5/8/2014 | 4,531 | 0.1% | 15,088 | 3/31/2014 |
| 2013 Q4 | 2/7/2014 | 4,126 | 0.1% | 14,991 | 12/31/2013 |